<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">Pharmacovigilance, as defined by the European Union directive 2010/84/EU [
 <xref ref-type="bibr" rid="CR41">41</xref>], regulation 1235/2010 [
 <xref ref-type="bibr" rid="CR42">42</xref>], Good Vigilance Practices â€“ Module IX [
 <xref ref-type="bibr" rid="CR7">7</xref>], and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, efficacy guidelines E2A to E2F [
 <xref ref-type="bibr" rid="CR43">43</xref>], will serve as references to contextualize pharmacovigilance in a global landscape.
</p>
